Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

So now we know that around November 11th IPCI will receive yet another Nasdaq delisting notification and another hearing will be scheduled if the share price remains priced under $1 over these next 2 weeks.

It's beyond hilarious how Odidi couldn't even get the recent reverse split ratio right and is already facing yet another Nasdaq delisting despite spending the majority of his time this year supposedly making steps to preserve their Nasdaq listing lol.

Still find it amazing how all IPCI ever puts out to market is negative news flow and lots of it and can't advance their dead pipeline at all anymore.

And sure enough the clock runs out with Mallinkrodt on their remaining 2 ANDA licensing deals with them in only a couple more months time now since IPCI couldn't even get FDA approval on Pristiq and Lamictal by/b4 Dec 31st 2018.

And now even if the FDA does ever get around to approving either 1 of them IPCI has already missed the optimal commercialization window on both of them too...so both will simply join Keppra and Glucophage and collect dust on the same shelf in the basement of IPCI's HQ's right...and rest assured mgmt. will still pay themselves big bonuses regardless for their collective pathetic performance if they do finally succeed in getting both/either FDA approved some day lol.

Now the next miracle IPCI's shareholders are waiting for is an unlikely push to share prices over +$1 again sometime over these next 2 weeks...and logic strongly suggests that's a very unlikely thing to happen given the ongoing severe lack of progress this company continues to suffer through.

I still find it mind boggling how Odidi could provide so much relevant progress in IPCI's 1st 5 years and then do a complete 180 and provide such a severe lack of relevant progress over the past 5 years to the point of almost completely wiping out his round 1 joe retail shareholders who find themselves sitting with a pre r/s equivalent share price of 5 cents sigh!